Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

Registrants may voluntarily include a summary of information required by Form 10-K under this Item 16. The Company has not elected to include such summary information.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Medtronic plc
Dated: June 18, 2026By:/s/ Geoffrey S. Martha
Geoffrey S. Martha
Chairman and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, the report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Medtronic plc
Dated: June 18, 2026By:/s/ Geoffrey S. Martha
Geoffrey S. Martha
Chairman and Chief Executive Officer
(Principal Executive Officer)
Dated: June 18, 2026By:/s/ Thierry Piéton
Thierry Piéton
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
Dated: June 18, 2026By:/s/ Denise L. Blomquist
Denise L. Blomquist
Vice President, Global Controller and Chief Accounting Officer
(Principal Accounting Officer)
Directors
Craig Arnold*
Scott C. Donnelly*
Lidia Fonseca*
John Groetelaars*
Randall J. Hogan, III*
William Jellison*
Joon Lee, M.D.*
Gregory P. Lewis*
Kevin E. Lofton*
Geoffrey S. Martha
Elizabeth G. Nabel, M.D.*
Kendall J. Powell*

*Michelle Quinn, by signing her name hereto, does hereby sign this document on behalf of each of the above named directors of the registrant pursuant to powers of attorney duly executed by such persons.

Dated: June 18, 2026By:/s/ Michelle Quinn
Michelle Quinn

Previous: Item 15. Exhibits and Financial Statement Schedules